Dimensional Fund Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.5M Buy
408,388
+7,488
+2% +$907K 0.01% 1667
2026
Q1
$65.5M Buy
400,900
+1,827
+0.5% +$281K 0.01% 1351
2025
Q4
$69.5M Buy
399,073
+12,402
+3% +$2.26M 0.01% 1324
2025
Q3
$55.7M Sell
386,671
-25,073
-6% -$3.07M 0.01% 1462
2025
Q2
$41.4M Buy
411,744
+39,744
+11% +$3.04M 0.01% 1605
2025
Q1
$28.4M Buy
372,000
+21,061
+6% +$1.61M 0.01% 1778
2024
Q4
$24.2M Sell
350,939
-16,313
-4% -$1.17M 0.01% 1910
2024
Q3
$26.8M Buy
367,252
+355,163
+2,938% +$26.2M 0.01% 1854
2024
Q2
$810K Buy
+12,089
New +$469K ﹤0.01% 2939
2024
Q1
Sell
-73,073
Closed -$2.26M 3419
2023
Q4
$2.26M Buy
73,073
+954
+1% +$24.7K ﹤0.01% 2765
2023
Q3
$1.82M Buy
72,119
+1,057
+1% +$24.2K ﹤0.01% 2803
2023
Q2
$1.5M Sell
71,062
-811
-1% -$15.4K ﹤0.01% 2853
2023
Q1
$1.23M Buy
+71,873
New +$1.4M ﹤0.01% 2858
2022
Q3
$2.38M Sell
110,412
-74,639
-40% -$1.79M ﹤0.01% 2660
2022
Q2
$3.65M Sell
185,051
-439,258
-70% -$9.2M ﹤0.01% 2546
2022
Q1
$14.7M Buy
624,309
+215,093
+53% +$5M ﹤0.01% 2132
2021
Q4
$11.1M Buy
409,216
+293,890
+255% +$8.4M ﹤0.01% 2267
2021
Q3
$3.17M Buy
+115,326
New +$3.03M ﹤0.01% 2716
2020
Q3
Sell
-205,940
Closed -$5.67M 3348
2020
Q2
$5.67M Sell
205,940
-66,106
-24% -$1.57M ﹤0.01% 2438
2020
Q1
$4.36M Sell
272,046
-13,190
-5% -$313K ﹤0.01% 2467
2019
Q4
$6.81M Buy
285,236
+22,905
+9% +$466K ﹤0.01% 2506
2019
Q3
$4.63M Sell
262,331
-448,008
-63% -$8.65M ﹤0.01% 2623
2019
Q2
$18.2M Sell
710,339
-20,347
-3% -$567K 0.01% 2107
2019
Q1
$21.2M Sell
730,686
-51,928
-7% -$1.35M 0.01% 2017
2018
Q4
$10.3M Buy
782,614
+565,297
+260% +$9.02M ﹤0.01% 2331
2018
Q3
$4.4M Buy
+217,317
New +$4.91M ﹤0.01% 2716
2014
Q1
Sell
-4,336
Closed -$74K 3597
2013
Q4
$74K Hold
4,336
﹤0.01% 3383
2013
Q3
$68K Sell
4,336
-200
-4% -$2.54K ﹤0.01% 3421
2013
Q2
$54K Buy
+4,536
New +$46.4K ﹤0.01% 3434

Other funds holding INSM

Dimensional Fund Advisors's INSM Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Insmed (INSM) stake by 1.9% in Q2 2026, buying an estimated $907K and bringing the position to 408,388 shares worth $43.5M. The position accounts for 0.01% of the portfolio, ranked #1667.

Dimensional Fund Advisors first reported a position in INSM in Q2 2013 and has held it in 29 quarters since. The position peaked at $69.5M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Dimensional Fund Advisors held 408,388 shares of Insmed worth $43.5M as of Q2 2026.
  • Dimensional Fund Advisors bought 7,488 Insmed shares in Q2 2026, an estimated $907K.
  • Insmed made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1667 holding.
  • Dimensional Fund Advisors first reported a position in Insmed in Q2 2013 and has held it in 29 quarters since.
  • Dimensional Fund Advisors's Insmed position peaked at $69.5M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.